Literature DB >> 7769667

Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41.

J Arroyo1, M Boceta, M E González, M Michel, L Carrasco.   

Abstract

The transmembrane glycoprotein (gp41) of human immunodeficiency virus type 1 (HIV-1) has been implicated in the cytopathology observed during HIV infection. The first amino acids located at the amino terminus are involved in membrane fusion and syncytium formation, while sequences located at the carboxy terminus have been predicted to interact with membranes and modify membrane permeability. The HIV-1 gp41 gene has been cloned and expressed in Escherichia coli cells by using pET vectors to analyze changes in membrane permeability produced by this protein. This system is well suited for expressing toxic genes in an inducible manner and for analyzing the function of proteins that modify membrane permeability. gp41 enhances the permeability of the bacterial membrane to hygromycin B despite the low level of expression of this protein. To localize the regions of gp41 responsible for these effects, a number of fragments spanning different portions of gp41 were inducibly expressed in E. coli. Two regions of gp41 were shown to increase membrane permeability: one located at the carboxy terminus, where two highly amphipathic helices have been predicted, and another one corresponding to the membrane-spanning domain. Expression of the central region of gp41 comprising this domain was highly lytic for E. coli cells and increased membrane permeability to a number of compounds. These findings are discussed in the light of HIV-induced cytopathology and gp41 structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769667      PMCID: PMC189144          DOI: 10.1128/JVI.69.7.4095-4102.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Interactions between membranes and cytolytic peptides.

Authors:  A W Bernheimer; B Rudy
Journal:  Biochim Biophys Acta       Date:  1986-06-12

2.  Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.

Authors:  S S Chen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

3.  Membrane leakiness after viral infection and a new approach to the development of antiviral agents.

Authors:  L Carrasco
Journal:  Nature       Date:  1978-04-20       Impact factor: 49.962

4.  Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity.

Authors:  R J Owens; C Burke; J K Rose
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.

Authors:  M A Miller; M W Cloyd; J Liebmann; C R Rinaldo; K R Islam; S Z Wang; T A Mietzner; R C Montelaro
Journal:  Virology       Date:  1993-09       Impact factor: 3.616

6.  Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.

Authors:  S S Chen; C N Lee; W R Lee; K McIntosh; T H Lee
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.

Authors:  G D Ritter; M J Mulligan; S L Lydy; R W Compans
Journal:  Virology       Date:  1993-11       Impact factor: 3.616

Review 8.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  Action of membrane-active compounds on mammalian cells. Permeabilization of human cells by ionophores to inhibitors of translation and transcription.

Authors:  M A Alonso; L Carrasco
Journal:  Eur J Biochem       Date:  1980-08

10.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

View more
  18 in total

1.  Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.

Authors:  S C Piller; J W Dubay; C A Derdeyn; E Hunter
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

3.  Rotavirus nonstructural glycoprotein NSP4 alters plasma membrane permeability in mammalian cells.

Authors:  K Newton; J C Meyer; A R Bellamy; J A Taylor
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Authors:  H Zhang; G Dornadula; P Alur; M A Laughlin; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.

Authors:  H Zhang; G Dornadula; R J Pomerantz
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Scylla serrata reovirus p35 protein expressed in Escherichia coli cells alters membrane permeability.

Authors:  Zhao Zhang; Yangyang Yuan; Dongyang Fan; Jifang Yang; Zhijuan Mao; Yan Yan; Jigang Chen
Journal:  Virus Genes       Date:  2015-06-24       Impact factor: 2.332

7.  Bovine ephemeral fever rhabdovirus α1 protein has viroporin-like properties and binds importin β1 and importin 7.

Authors:  D Albert Joubert; Kim R Blasdell; Michelle D Audsley; Lee Trinidad; Paul Monaghan; Keyur A Dave; Kim G Lieu; Rachel Amos-Ritchie; David A Jans; Gregory W Moseley; Jeffrey J Gorman; Peter J Walker
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

8.  Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus.

Authors:  Y S Chang; C L Liao; C H Tsao; M C Chen; C I Liu; L K Chen; Y L Lin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.

Authors:  G D Ritter; G Yamshchikov; S J Cohen; M J Mulligan
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.

Authors:  U Schubert; S Bour; R L Willey; K Strebel
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.